119 related articles for article (PubMed ID: 35325303)
1. Structure-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation of VEGF inhibitors for the clinical treatment of Ovarian Cancer.
Mukherjee S; Abdalla M; Yadav M; Madhavi M; Bhrdwaj A; Khandelwal R; Prajapati L; Panicker A; Chaudhary A; Albrakati A; Hussain T; Nayarisseri A; Singh SK
J Mol Model; 2022 Mar; 28(4):100. PubMed ID: 35325303
[TBL] [Abstract][Full Text] [Related]
2. Identification of Potent VEGF Inhibitors for the Clinical Treatment of Glioblastoma, A Virtual Screening Approach.
Yadav M; Khandelwal R; Mudgal U; Srinitha S; Khandekar N; Nayarisseri A; Vuree S; Singh SK
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2681-2692. PubMed ID: 31554364
[TBL] [Abstract][Full Text] [Related]
3. A Computer - Aided Drug Designing for Pharmacological Inhibition of Mutant ALK for the Treatment of Non-small Cell Lung Cancer.
Sharda S; Khandelwal R; Adhikary R; Sharma D; Majhi M; Hussain T; Nayarisseri A; Singh SK
Curr Top Med Chem; 2019; 19(13):1129-1144. PubMed ID: 31109278
[TBL] [Abstract][Full Text] [Related]
4. In Silico Insights on GD2 : A Potential Target for Pediatric Neuroblastoma.
Limaye A; Sweta J; Madhavi M; Mudgal U; Mukherjee S; Sharma S; Hussain T; Nayarisseri A; Singh SK
Curr Top Med Chem; 2019; 19(30):2766-2781. PubMed ID: 31721713
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Virtual Screening for the Identification of High Affinity Compounds as Potent VEGFR2 Inhibitors for the Treatment of Renal Cell Carcinoma.
Sharma K; Patidar K; Ali MA; Patil P; Goud H; Hussain T; Nayarisseri A; Singh SK
Curr Top Med Chem; 2018; 18(25):2174-2185. PubMed ID: 30499413
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics guided insight, binding free energy calculations and pharmacophore-based virtual screening for the identification of potential VEGFR2 inhibitors.
Rathi E; Kumar A; Kini SG
J Recept Signal Transduct Res; 2019; 39(5-6):415-433. PubMed ID: 31755336
[TBL] [Abstract][Full Text] [Related]
7. Computer-aided Drug Designing for the Identification of High-Affinity Small Molecule Targeting CD20 for the Clinical Treatment of Chronic Lymphocytic Leukemia (CLL).
Sinha K; Majhi M; Thakur G; Patidar K; Sweta J; Hussain T; Nayarisseri A; Singh SK
Curr Top Med Chem; 2018; 18(29):2527-2542. PubMed ID: 30526461
[TBL] [Abstract][Full Text] [Related]
8. Structure-based Virtual Screening for the Identification of High-affinity Small Molecule Towards STAT3 for the Clinical Treatment of Osteosarcoma.
Khandelwal R; Chauhan APS; Bilawat S; Gandhe A; Hussain T; Hood EA; Nayarisseri A; Singh SK
Curr Top Med Chem; 2018; 18(29):2511-2526. PubMed ID: 30430945
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation of EGFR for the Clinical Treatment of Glioblastoma.
Bhrdwaj A; Abdalla M; Pande A; Madhavi M; Chopra I; Soni L; Vijayakumar N; Panwar U; Khan MA; Prajapati L; Gujrati D; Belapurkar P; Albogami S; Hussain T; Selvaraj C; Nayarisseri A; Singh SK
Appl Biochem Biotechnol; 2023 Aug; 195(8):5094-5119. PubMed ID: 36976507
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: Structure-based virtual screening, ADMET prediction and molecular dynamics studies.
Weako J; Uba AI; Keskin Ö; Gürsoy A; Yelekçi K
Comput Biol Chem; 2020 Jun; 86():107244. PubMed ID: 32252002
[TBL] [Abstract][Full Text] [Related]
11. Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products.
Luo L; Zhong A; Wang Q; Zheng T
Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049884
[TBL] [Abstract][Full Text] [Related]
12. Identification of High-affinity Small Molecules Targeting Gamma Secretase for the Treatment of Alzheimer's Disease.
Ali MA; Vuree S; Goud H; Hussain T; Nayarisseri A; Singh SK
Curr Top Med Chem; 2019; 19(13):1173-1187. PubMed ID: 31244427
[TBL] [Abstract][Full Text] [Related]
13. Virtual Screening of IL-6 Inhibitors for Idiopathic Arthritis.
Shukla P; Khandelwal R; Sharma D; Dhar A; Nayarisseri A; Singh SK
Bioinformation; 2019; 15(2):121-130. PubMed ID: 31435158
[TBL] [Abstract][Full Text] [Related]
14. Structural Insights into the Molecular Design of ROS1 Inhibitor for the Treatment of Non-Small Cell Lung Cancer (NSCLC).
Adhikary R; Khandelwal R; Hussain T; Nayarisseri A; Singh SK
Curr Comput Aided Drug Des; 2021; 17(3):387-401. PubMed ID: 32364080
[TBL] [Abstract][Full Text] [Related]
15. Ligand-based pharmacophore modeling of TNF-α to design novel inhibitors using virtual screening and molecular dynamics.
Jade DD; Pandey R; Kumar R; Gupta D
J Biomol Struct Dyn; 2022 Mar; 40(4):1702-1718. PubMed ID: 33034255
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
Starzec A; Miteva MA; Ladam P; Villoutreix BO; Perret GY
Bioorg Med Chem; 2014 Aug; 22(15):4042-8. PubMed ID: 24961874
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
18. In silico approaches to identify novel myeloid cell leukemia-1 (Mcl-1) inhibitors for treatment of cancer.
Ren JX; Li CP; Zhou XL; Cao XS; Xie Y
J Biomol Struct Dyn; 2018 Jul; 36(9):2424-2435. PubMed ID: 28714799
[TBL] [Abstract][Full Text] [Related]
19. A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma.
Qureshi S; Khandelwal R; Madhavi M; Khurana N; Gupta N; Choudhary SK; Suresh RA; Hazarika L; Srija CD; Sharma K; Hindala MR; Hussain T; Nayarisseri A; Singh SK
Curr Top Med Chem; 2021; 21(9):790-818. PubMed ID: 33463471
[TBL] [Abstract][Full Text] [Related]
20. Design of PD-L1 inhibitors for lung cancer.
Udhwani T; Mukherjee S; Sharma K; Sweta J; Khandekar N; Nayarisseri A; Singh SK
Bioinformation; 2019; 15(2):139-150. PubMed ID: 31435160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
